Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

Following “positive” top-line phase II trial results, neurodegenerative disease house Alterity Therapeutics (ASX:ATH) will ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Neurostimulation Devices market Research Report. WILMINGTON, DE, UNITED STATES, January 29, 2025 /EINPresswire / -- As of 2018, the global neurostimulation ...

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

Kevin Hill, 65, used to suffer sleepless nights due to his harrowing Parkinson's disease symptoms. Now, he forgets about his ...

U.S. Department of Defense awards $4 million to researchers at OHSU, University of Washington, VA Portland, VA Puget Sound to ...

The bill, in its current form, says an eligible patient must have the approval of two independent doctors and the High Court.

Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. In the United ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

According to Mayo Clinic, Parkinson’s disease is a progressive disorder of the central nervous system that affects movement.

Yulan Xiong, associate professor of neuroscience at UConn Health, and her team have discovered one more piece of the puzzle ...